AGM - Revised Form of Proxy.


    25 June 2025 23:05:11
  • Source: Sharecast
RNS Number : 2437O
Halma PLC
25 June 2025
 

Halma plc

 

Annual General Meeting 2025 (AGM) - Revised Form of Proxy

 

Following the publication and posting of the Notice of AGM of the Company to be held on 24 July 2025, together with a Form of Proxy, it has come to the Company's attention that the Form of Proxy contains a minor typographical error in relation to resolution 5. For the avoidance of doubt, the resolutions set out in the 2025 Notice of AGM are correct and the typographical error in the Form of Proxy does not affect the validity of the resolutions. 

 

A Form of Proxy which has been submitted, or which is submitted prior to the proxy voting deadline of 12.30pm on 22 July 2025, will be treated as valid, notwithstanding the typographical error. As such, shareholders who have already returned their Form of Proxy do not need to take any action. A revised Form of Proxy is available on the Company's website at https://www.halma.com/investors/shareholder-information/agm-information.  Shareholders who have not yet returned a Form of Proxy, or who wish to amend their original submission, may use the revised Form of Proxy, if preferred.  

 

The revised Form of Proxy has also been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

 

For further information, please contact:


 


Mark Jenkins

Company Secretary, Halma plc

Tel: +44 (0)1494 721111


 

NOTE TO EDITORS

 

Halma is a global group of life-saving technology companies, focused on growing a safer, cleaner, healthier future for everyone, every day. Its purpose defines the three market areas where it operates:

 

·      Safety

Protecting people, assets and infrastructure in commercial, industrial and public spaces. Reducing safety risks in hazardous situations, increasing efficiency and helping to create a more sustainable future.

 

·      Environmental & Analysis

Monitoring and protecting the environment, and ensuring the quality and availability of lifecritical resources. Creating solutions used in materials analysis and optoelectronic applications.

 

·      Healthcare

 

 

Improving the care delivered by healthcare providers, and enhancing the quality of patients' lives, through contributing to the discovery and development of new cures, the diagnosis and treatment of patient conditions, and data analysis.

           

Halma employs over 9,000 people in more than 20 countries, with major operations in the UK, Mainland Europe, the USA and Asia Pacific. Halma is listed on the London Stock Exchange (LON: HLMA) and is a constituent of the FTSE 100 index.

 

Halma has been named one of Britain's Most Admired Companies for the past six years.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCGZGZVVDVGKZM

Compare our accounts

If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.

Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.